NIOX Group Plc (AIM:NIOX)

London flag London · Delayed Price · Currency is GBP · Price in GBX
67.60
-0.40 (-0.59%)
Apr 28, 2026, 4:35 PM GMT
10.10%
Market Cap 285.88M
Revenue (ttm) 48.70M
Net Income (ttm) 7.00M
Shares Out 420.41M
EPS (ttm) 0.02
PE Ratio 41.47
Forward PE 18.29
Dividend 0.02 (2.28%)
Ex-Dividend Date May 21, 2026
Volume 1,391,935
Average Volume 894,279
Open 67.60
Previous Close 68.00
Day's Range 66.80 - 69.80
52-Week Range 53.84 - 77.60
Beta -0.09
RSI 71.55
Earnings Date Sep 24, 2026

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Pl... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 2006
Employees 97
Stock Exchange London Stock Exchange AIM
Ticker Symbol NIOX
Full Company Profile

Financial Performance

In 2025, NIOX Group's revenue was 48.70 million, an increase of 16.51% compared to the previous year's 41.80 million. Earnings were 7.00 million, an increase of 89.19%.

Financial Statements

News

There is no news available yet.